Suppr超能文献

[初始白细胞计数高于50,000/mm³的儿童急性淋巴细胞白血病:波兰儿科白血病/淋巴瘤研究组的治疗结果总结]

[Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].

作者信息

Skoczeń Szymon, Balwierz Walentyna, Moryl-Bujakowska Angelina, Pawińska Katarzyna, Luszczyńska Aleksandra, Balcerska Anna, Płoszyńska Anna, Chybicka Alicja, Dobaczewski Grzegorz, Juszczak Katarzyna, Wachowiak Jacek, Derwich Katarzyna, Kowalczyk Jerzy, Wiśniewska-Slusarz Hanna, Matysiak Michał, Krauze Agnieszka, Pawelec Katarzyna, Sońta-Jakimczyk Danuta, Tomaszewska Renata, Wysocki Mariusz, Styczyńskii Jan, Swiatkiewicz Violetta

机构信息

Klinika Onkologii i Hematologii Dzieciecej P-A Instytutu Pediatrii Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.

出版信息

Przegl Lek. 2006;63(1):11-4.

Abstract

Initial leucocytosis, presence of t(9;22) and t(4;11) translocations and poor response to therapy with steroids or induction chemotherapy are still included to poor risk factors group. From 1981 to 1986, children with acute lymphoblastic leukemia (ALL) and initial WBC above 50,000/mm3, achieved significantly worse treatment results than children with lower WBC: over 6-year disease-free survival were respectively 33% and 60%. In attempt to improve treatment results in children with hyperleucocytosis, modified American protocols called: New York (1987), New York I (1997), and New York II (1999) were introduced consecutively in the centers of Polish Pediatric Leukemia/ Lymphoma Study Group. Actually treatment results obtained with those protocols in three groups of patients: group I: 214 children (1987-1996), group II: 58 children (1997-1999), and group III: 77 children (1999-2001) are presented. The observation was completed in March 31, 2004. In evaluated groups the first complete remissions (CR) were achieved in 91%, 95%, and 96% of patients, respectively. Relapses occurred in 72 patients of group I (37%), in 12 patients of group II (21%), and in 13 patients of group III (18%). The 5-year overall survivals were: 62%, 79%, and 78% (p=0.05) respectively; 5 year event-free survivals (EFS) were: 52%, 74%, and 69% (p=0.01) respectively. A significant improvement in treatment results in second compared with first group was achieved. Treatment results obtained with New York II are comparable with results obtained with New York I. The analysis of treatment results achieved shows the improvement of the prognosis in children with ALL and initial WBC above 50 000/mm3 in comparison with patients treated before 1987. There is strong necessity of unification of risk group qualification criteria in childhood ALL in term of comparable estimation treatment results achieved in different centers all over the world.

摘要

初始白细胞增多、存在t(9;22)和t(4;11)易位以及对类固醇或诱导化疗反应不佳仍被纳入高危因素组。1981年至1986年期间,急性淋巴细胞白血病(ALL)且初始白细胞计数高于50,000/mm³的儿童,其治疗效果明显比白细胞计数较低的儿童差:6年无病生存率分别为33%和60%。为了改善高白细胞血症患儿的治疗效果,波兰儿童白血病/淋巴瘤研究组的各中心相继引入了改良的美国方案,即纽约方案(1987年)、纽约I方案(1997年)和纽约II方案(1999年)。本文展示了使用这些方案对三组患者的治疗结果:第一组:214名儿童(1987 - 1996年),第二组:58名儿童(1997 - 1999年),第三组:77名儿童(1999 - 2001年)。观察于2004年3月31日结束。在评估的各组中,分别有91%、95%和96%的患者实现了首次完全缓解(CR)。第一组72名患者(37%)、第二组12名患者(21%)和第三组13名患者(18%)出现复发。5年总生存率分别为:62%、79%和78%(p = 0.05);5年无事件生存率(EFS)分别为:52%、74%和69%(p = 0.01)。与第一组相比,第二组的治疗效果有显著改善。纽约II方案获得的治疗结果与纽约I方案相当。对所取得的治疗结果进行分析表明,与1987年以前接受治疗的患者相比,ALL且初始白细胞计数高于50,000/mm³的儿童预后有所改善。从全世界不同中心所取得的可比治疗结果来看,在儿童ALL的风险组资格标准统一方面有迫切的必要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验